|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2006-4-12
|
|
pubmed:abstractText |
To retrospectively evaluate the prognosis of patients with hepatocellular carcinoma (HCC) with or without a history of therapy for HCC following transcatheter arterial embolization (TAE).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
pubmed-author:HiasaYoichiY,
pubmed-author:HiraokaAtsushiA,
pubmed-author:HirookaMasashiM,
pubmed-author:HoriikeNorioN,
pubmed-author:IuchiHidehitoH,
pubmed-author:KumagiTeruT,
pubmed-author:KumanoSeishiS,
pubmed-author:KuroseKiyotakaK,
pubmed-author:MatsuuraBunzoB,
pubmed-author:MichitakaKojiroK,
pubmed-author:MochizukiTeruhitoT,
pubmed-author:OnjiMorikazuM,
pubmed-author:TanakaHiroakiH,
pubmed-author:UeharaTakahideT,
pubmed-author:YamashitaYoshimasaY
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2075-9
|
|
pubmed:meshHeading |
pubmed-meshheading:16610060-Aged,
pubmed-meshheading:16610060-Carcinoma, Hepatocellular,
pubmed-meshheading:16610060-Chemoembolization, Therapeutic,
pubmed-meshheading:16610060-Female,
pubmed-meshheading:16610060-Humans,
pubmed-meshheading:16610060-Liver Neoplasms,
pubmed-meshheading:16610060-Male,
pubmed-meshheading:16610060-Middle Aged,
pubmed-meshheading:16610060-Prognosis,
pubmed-meshheading:16610060-Retrospective Studies,
pubmed-meshheading:16610060-Survival Rate,
pubmed-meshheading:16610060-alpha-Fetoproteins
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment.
|
|
pubmed:affiliation |
Third Department of Internal Medicine, Ehime University School of Medicine, Ehime 791-0295, Japan.
|
|
pubmed:publicationType |
Journal Article
|
